Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences

Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences

Source: 
Mass Device
snippet: 

Boston Scientific (NYSE:BSX) today claimed a win in an ongoing patent spat with Edwards Lifesciences (NYSE:EW) over transcatheter aortic valve replacement system patents.